Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro

See allHide authors and affiliations

Science  11 Dec 1987:
Vol. 238, Issue 4833, pp. 1566-1568
DOI: 10.1126/science.3685994

This article has a correction. Please see:


One mechanism considered responsible for the hypercalcemia that frequently accompanies malignancy is secretion by the tumor of a circulating factor that alters calcium metabolism. The structure of a tumor-secreted peptide was recently determined and found to be partially homologous to parathyroid hormone (PTH). The amino-terminal 1-34 region of the factor was synthesized and evaluated biologically. In vivo it produced hypercalcemia, acted on bone and kidney, and stimulated 1,25-dihydroxy-vitamin D3 formation. In vitro it interacted with PTH receptors and, in some systems, was more potent than PTH. These studies support a long-standing hypothesis regarding pathogenesis of malignancy-associated hypercalcemia.